About
Flightpath Biosciences develops therapies that selectively eliminate harmful gram-negative bacteria to treat infection-driven complex diseases without damaging the surrounding microbiome.
Explore Flightpath Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.